Terms: = Skin cancer AND CARD11, BIMP3, 84433, ENSG00000198286, CARMA1, MGC133069, Q9BXL7 AND Diagnosis
3 results:
1. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
2. Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.
Ducharme O; Beylot-Barry M; Pham-Ledard A; Bohers E; Viailly PJ; Bandres T; Faur N; Frison E; Vergier B; Jardin F; Merlio JP; Gros A
J Invest Dermatol; 2019 Nov; 139(11):2334-2342.e8. PubMed ID: 31150604
[TBL] [Abstract] [Full Text] [Related]
3. Sézary Syndrome: Translating Genetic Diversity into Personalized Medicine.
Chevret E; Merlio JP
J Invest Dermatol; 2016 Jul; 136(7):1319-1324. PubMed ID: 27342034
[TBL] [Abstract] [Full Text] [Related]